HOME >> BIOLOGY >> NEWS
One-way processes speed degradation of coral reefs

Efforts to protect coral reefs should be refocused on terminating self-reinforcing processes that accelerate degradation of these biological marvels, according to a Forum article published in the November 2004 issue of BioScience. The article, by Charles Birkeland of the University of Hawaii at Manoa, blames a series of "ratchets"---destructive forces that are hard to reverse---for the failure of most current efforts to halt continuing losses.

Birkeland identifies seven ecological ratchets that seem to contribute to the loss of coral reefs, including a decrease of corals' reproductive success that may occur at lower population densities, the disproportionate survival of coral predators, and the ability of algae, which can prevent the establishment of new corals, to outgrow grazers. Birkeland also points to technological ratchets, economic ratchets, cultural ratchets, and conceptual ratchets.

Technological advances such as scuba, night lights, monofilament nets, and the global positioning system, for example, make it easier for fishers to pursue coral reef fishes.

Economic demand for rare and wild-caught fishes fosters investment in ever more sophisticated fishing equipment. And as expectations about coral reef productivity decrease, efforts to restore reefs are undermined. Birkeland proposes that organizations concerned about coral reefs should develop interventions that focus on preventing degradation, rather than on restoration. He also suggests that encouraging responsible stewardship would be easier if there were a return to local management of coral reef resources.

Journalists may obtain copies of the article, "Ratcheting Down the Coral Reefs," by contacting Donna Royston, AIBS communications representative. BioScience publishes commentary and peer-reviewed articles covering a wide range of biological fields, including ecology. The journal has been published since 1964. AIBS is an umbrella organization for professional scien
'"/>

Contact: Donna Royston
droyston@aibs.org
202-628-1500 ext. 261
American Institute of Biological Sciences
1-Nov-2004


Page: 1 2

Related biology news :

1. The UAB heads a European research project on proteases and pathological processes
2. A rainbow of methods promises insights into biological processes and diseases
3. Fruit fly gene research may shed light on human disease processes
4. UGA research shows rats are capable of reflecting on mental processes
5. Scientists uncover link between oceans chemical processes and microscopic floating plants
6. Elderlys ability to manage the cold may be due in part to some aging processes of the body
7. Intelligent software solutions to better understand biological processes
8. NYU biologists identify gene that coordinates two cellular processes
9. Protective action of a molecule in inflammatory processes discovered
10. Bioenergy - I: From concept to commercial processes
11. NSF awards 19 new projects to better undestand genetic processes in plants of economic importance

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: One way processes speed degradation coral reefs

(Date:2/13/2015)... , Feb. 13, 2015 ACT ... company that aims to transform cancer genomic information ... that the company has raised US$ 8 million in ... Based in Taipei, Taiwan , ... ACTDrug™, ACTOnco™. With the aim to implement next ...
(Date:2/9/2015)... RICHARDSON, Texas , Feb. 9, 2015  Lintec ... novel fabrication methods for carbon nanotube (CNT) macrostructures, including ... Texas at Dallas (UTD). Leveraging the vast ... Tokyo, Japan , Lintec of America ... Richardson, TX , focusing on scaling ...
(Date:2/5/2015)... 2015   Marvin Test Solutions , ... test solutions for military, aerospace, and manufacturing ... TS-323 GENASYS Test Platform to ... is a high-performance PXI-based system designed to ... require performance functional testing. GENASYS features a ...
Breaking Biology News(10 mins):ACT Genomics Raises $8 Million in its First Private Funding Round 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4
(Date:2/28/2015)... 2015 Increasing its efforts to resolve the ... first three episodes of The GMO TRUTH podcast on both ... as it continues its mission to discover the truth and ... phase, to “uncover the truth about the GMOs in our ... GMO Truth Podcast is an expansion of the documentary/investigative film-making ...
(Date:2/27/2015)... Calif. , Feb. 27, 2015  Pharmacyclics, ... that longer-term toxicology studies for its newly developed ... or RA, have been completed. The results of ... U.S. Food and Drug Administration. The feedback received ... of the ongoing first-in-human study. Additional preclinical work ...
(Date:2/27/2015)... Halifax, Nova Scotia (PRWEB) February 27, 2015 ... clinical stage vaccine and immunotherapy company, today announced ... approved its application for Fast Track designation and ... DPX-Ebola vaccines, in conjunction with the mutual co-development ... had previously obtained Fast Track designation for the ...
(Date:2/27/2015)... , Feb. 27, 2015  Pfenex Inc. (NYSE ... development of biosimilar therapeutics, today announced that it will ... Marriott Marquis on March 2 nd at 3pm ... on a panel discussing the current state of the ... Biosimilars . For more information on ...
Breaking Biology Technology:The Walk a Mile Project Launches “GMO Truth” Podcast 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3
Cached News: